Clinical trial Recruiting at 1 site Phase 1 Interventional Ages 14 to 89 Women only

Pilot project on treating hypertension during pregnancy

Official title: Treatment of American Heart Association/American College of Cardiology Stage 1 Hypertension in Pregnancy: A Randomized Control Trial

Run by University of Alabama at Birmingham · NCT05989581 · Data updated 2026-11-12

This study is testing if treating high blood pressure earlier in pregnant women can help improve their baby's birth weight compared to usual care.

Quick facts

PhasePhase 1
Study typeInterventional
Ages14 Years to 89 Years
SexWomen only
Enrollment74 (estimated)
SponsorUniversity of Alabama at Birmingham
Academic / other
Locations1 site (Birmingham, Alabama)
StatusRecruiting
StartedApril 24, 2024
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedAugust 11, 2026
Trial IDNCT05989581 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pregnant women with stage 1 hypertension planning to deliver at UAB Hospital.

Probably not a fit

Patients with chronic hypertension or those requiring more stringent blood pressure control will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The CHAP2 pilot project aims to gather preliminary data for a larger multicenter study focused on the treatment of stage 1 hypertension in pregnant women. This study will randomize participants to either a treatment group aiming for blood pressure below 130/80 mmHg or a usual care group, where treatment is only initiated if blood pressure reaches 140/90 mmHg. The primary goal is to assess whether achieving lower blood pressure targets can positively influence birthweight percentiles at delivery. A total of 74 eligible participants will be enrolled in this pilot study at UAB Hospital.

Why it matters

Potential benefit: If successful, this study could lead to improved maternal and neonatal outcomes for pregnant women with stage 1 hypertension.

How similar studies have gone: While this pilot project is novel in its specific approach, similar studies have shown promise in managing hypertension during pregnancy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Viable singleton gestation
* No fetal anomalies
* Blood pressures 130-139/80-89mmHg on two occasions at least 4 hours apart prior to 20 weeks gestation
* Planning to deliver at UAB Hospital
* No indication for pregnancy termination
* Receiving care at the UAB prenatal clinics

Exclusion Criteria:

* Declines Randomization
* Known diagnosis of chronic hypertension ( BP ≥ 140/90mmHg) or current antihypertensive medication use
* Fetal demise diagnosed prior to enrollment
* Known major structural of chromosomal abnormalities prior to enrollment
* Contraindication to first line antihypertensive (Nifedipine/ Labetalol)
* Comorbidities requiring BP goals \< 130/80mmHg

Where it's running

  • UAB
    Birmingham, Alabama, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.